However, the multicenter open-label ANSWER study investigated the effect of long-term albumin administration (40 g twice weekly for two weeks and then 40 g weekly for up to 18 months) in patients with decompensated cirrhosis and uncomplicated ascites, and showed increased overall survival in the group of patients with long-term albumin administration. The gene discussed is ALB; the disease is Ascites.